AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2019
Jan 31, 2019
3174_iss_2019-01-31_3c56c6db-0a6f-4e3f-adaa-ba121270207c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument Instrument Aktier Before the transaction Shares Data not given Voting rights Data not given Transaction Reason for major shareholding notification Buy Date 30/01/2019 Limit for number of shares 10 % Limit for number of votes 10 % After the transaction Quantity Shares 1,771,675 Directly held voting rights 0 Indirectly held voting rights 1,771,675 |
|---|
| Percentage |
| Directly held shares 10.007 % |
| Directly held voting rights 0 % |
| Indirectly held voting rights 10.007 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 10.007 % | 1,771,675 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | 0.006 % | 1,000 |
| Total | 10.013 % | 1,772,675 |
Group total holdings
Voting rights 1,772,675 Percentage of voting rights 10.013
Notes (other relevant informations according to law)
Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har förvärvat de aktuella aktierna.
Published
31/01/2019 15:17
Contact
Name Joakim Lomell
Phone 08-40942107 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13